Paper Details

  1. Home
  2. Paper Details

Mirabegron versus Solifenacin in Children with Overactive Bladder: Prospective Randomized Single-Blind Controlled Trial.

Author: Abou-RamadanAhmed R, El-AbdAhmed S, El-AbdShawky, El-GamalOsama M, RaheemAli Abdel, SolimanMohamed G

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Both mirabegron and solifenacin showed comparable efficacy in controlling overactive bladder (OAB) symptoms in newly diagnosed children, with mirabegrone having less side effects.
Paper Details　
Original Abstract of the Article :
PURPOSE: The purpose of this study is to investigate the efficacy and safety of mirabegron versus solifenacin in the treatment of newly diagnosed overactive bladder (OAB) in children. METHODS: We conducted a prospective randomized controlled study on pediatric patients with newly diagnosed OAB. Pat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1159/000515992

データ提供：米国国立医学図書館（NLM）

Mirabegron vs. Solifenacin for Overactive Bladder in Children: A Comparative Study

Overactive bladder (OAB) is a common condition, particularly in children, a challenge akin to a mischievous desert wind playing tricks on a thirsty traveler. This study compares the efficacy and safety of mirabegron and solifenacin in treating OAB in children, a journey to find the most effective and tolerable treatment for this often embarrassing condition.

Navigating the Sands of OAB

The study found that both mirabegron and solifenacin effectively reduced OAB symptoms in children, a discovery like finding a reliable water source in a vast and arid desert. However, mirabegron demonstrated a lower incidence of side effects, offering a potentially more comfortable treatment experience for children.

Finding the Right Path to Relief

This study emphasizes the importance of finding the right treatment for OAB in children, just as a desert traveler must choose a suitable route for their journey. By understanding the relative efficacy and safety profiles of different medications, clinicians can make informed decisions that prioritize the well-being of their young patients. This research, like a compassionate guide helping a child navigate a challenging path, offers valuable insights into managing OAB in children.

Dr. Camel's Conclusion

This study compares the efficacy and safety of mirabegron and solifenacin in treating overactive bladder (OAB) in children, highlighting the potential benefits of mirabegron's lower incidence of side effects. This research, like a skilled navigator charting a safe course through a complex landscape, provides valuable information for clinicians seeking the best treatment options for their young patients.
Date :
  1. Date Completed 2022-02-09
  2. Date Revised 2022-02-09
Further Info :

Pubmed ID

34010843

DOI: Digital Object Identifier

10.1159/000515992

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.